Simplex Trading
NVAX icon

Simplex Trading’s Novavax NVAX Stock Holding History

Simplex Trading’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24M Sell
275,000
-67,200
-20% -$609K ﹤0.01% 1732
2025
Q4 		$2.3M Sell
342,200
-170,100
-33% -$1.28M ﹤0.01% 1865
2025
Q3 		$4.44M Sell
512,300
-114,000
-18% -$887K ﹤0.01% 1583
2025
Q2 		$3.94M Buy
626,300
+307,100
+96% +$2.03M ﹤0.01% 1547
2025
Q1 		$2.05M Sell
319,200
-839,000
-72% -$6.94M ﹤0.01% 2012
2024
Q4 		$9.31M Sell
1,158,200
-417,700
-27% -$4.03M 0.01% 1077
2024
Q3 		$19.9M Sell
1,575,900
-294,400
-16% -$3.8M 0.01% 655
2024
Q2 		$23.7M Buy
1,870,300
+344,400
+23% +$3.46M 0.01% 546
2024
Q1 		$7.29M Buy
1,525,900
+1,279,300
+519% +$5.93M ﹤0.01% 1329
2023
Q4 		$1.18M Sell
246,600
-66,100
-21% -$405K ﹤0.01% 2851
2023
Q3 		$2.26M Buy
312,700
+187,400
+150% +$1.5M ﹤0.01% 1965
2023
Q2 		$930K Sell
125,300
-102,300
-45% -$804K ﹤0.01% 2664
2023
Q1 		$1.58M Sell
227,600
-457,800
-67% -$4.21M ﹤0.01% 2153
2022
Q4 		$7.04M Buy
685,400
+445,200
+185% +$7.86M 0.01% 1033
2022
Q3 		$4.37M Sell
240,200
-141,300
-37% -$6.12M ﹤0.01% 1293
2022
Q2 		$19.6M Sell
381,500
-48,900
-11% -$2.53M 0.02% 507
2022
Q1 		$31.7M Sell
430,400
-154,600
-26% -$13.8M 0.03% 399
2021
Q4 		$83.7M Buy
585,000
+198,400
+51% +$34.1M 0.08% 177
2021
Q3 		$83.4M Buy
386,600
+1,500
+0.4% +$331K 0.08% 175
2021
Q2 		$81.8M Buy
385,100
+382,374
+14,027% +$70.1M 0.08% 173
2021
Q1 		$49.4M Sell
2,726
-769
-22% -$153K 0.09% 136
2020
Q4 		$39M Sell
3,495
-1,048
-23% -$111K 0.05% 211
2020
Q3 		$49.2M Buy
4,543
+1,648
+57% +$201K 0.07% 164
2020
Q2 		$24.1M Buy
2,895
+2,016
+229% +$77.1K 0.04% 263
2020
Q1 		$1.19M Buy
879
+324
+58% +$2.74K ﹤0.01% 1724
2019
Q4 		$220K Buy
555
+221
+66% +$959 ﹤0.01% 3652
2019
Q3 		$167K Buy
334
+95
+40% +$520 ﹤0.01% 3760
2019
Q2 		$139K Buy
239
+221
+1,228% +$1.74K ﹤0.01% 3858
2019
Q1 		$19K Sell
18
-8
-31% -$253 ﹤0.01% 5752
2018
Q4 		$94K Buy
26
+24
+1,200% +$930 ﹤0.01% 3908
2018
Q3 		$7K Buy
2
+1
+100% +$28 ﹤0.01% 6610
2018
Q2 		$2K Hold
1
– – ﹤0.01% 7047
2018
Q1 		$1K Sell
1
-10
-91% -$402 ﹤0.01% 5713
2017
Q4 		$3K Sell
11
-8
-42% -$195 ﹤0.01% 4945
2017
Q3 		$19K Buy
19
+5
+36% +$112 ﹤0.01% 3203
2017
Q2 		$22K Buy
14
+12
+600% +$235 ﹤0.01% 3219
2017
Q1 		$6K Sell
2
-34
-94% -$935 ﹤0.01% 4448
2016
Q4 		$182K Sell
36
-100
-74% -$2.92K 0.01% 1113
2016
Q3 		$598K Buy
136
+109
+404% +$14.1K 0.04% 438
2016
Q2 		$82K Sell
27
-9
-25% -$1.03K 0.01% 1633
2016
Q1 		$419K Buy
36
+8
+29% +$858 0.03% 514
2015
Q4 		$125K Sell
28
-29
-51% -$4.46K 0.01% 1192
2015
Q3 		$329K Buy
57
+40
+235% +$8.97K 0.02% 632
2015
Q2 		$16K Sell
17
-14
-45% -$2.46K ﹤0.01% 2664
2015
Q1 		$36K Buy
31
+17
+121% +$2.76K ﹤0.01% 1810
2014
Q4 		$4K Buy
+14
New +$1.46K ﹤0.01% 3272

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's NVAX Position: Q3 2025 in Review

Simplex Trading sold out of Novavax (NVAX) in Q3 2025, closing a stake of 216,099 shares — an estimated $1.68M sold.

Simplex Trading first reported a position in NVAX in Q1 2015 and held it in 30 quarters. The position peaked at $17.3M in Q4 2021. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Simplex Trading reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 216,099 Novavax shares in Q3 2025, an estimated $1.68M.
  • Simplex Trading first reported a position in Novavax in Q1 2015 and held it in 30 quarters.
  • Simplex Trading's Novavax position peaked at $17.3M in Q4 2021.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.